RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19111878http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19111878http://www.w3.org/2000/01/rdf-schema#comment"Tumor- or cancer-associated fibroblasts (TAFs or CAFs) from different tumors exhibit distinct angiogenic and tumorigenic properties. Unlike normal skin fibroblasts or TAFs from TIB6 tumors that are sensitive to anti-VEGF treatment (TAF-TIB6), TAFs from resistant EL4 tumors (TAF-EL4) can stimulate TIB6 tumor growth even when VEGF is inhibited. We show that platelet-derived growth factor C (PDGF-C) is upregulated in TAFs from resistant tumors. PDGF-C-neutralizing antibodies blocked the angiogenesis induced by such TAFs in vivo, slowed the growth of EL4 and admixture (TAF-EL4 + TIB6) tumors, and exhibited additive effects with anti-VEGF-A antibodies. Hence, our data reveal an additional mechanism for TAF-mediated tumorigenesis and suggest that some tumors may overcome inhibition of VEGF-mediated angiogenesis through upregulation of PDGF-C."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.org/dc/terms/identifier"doi:10.1016/j.ccr.2008.12.004"xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/author"Zhong C."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/author"Wu X."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/author"Yu L."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/author"Modrusan Z."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/author"Ferrara N."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/author"Kasman I."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/author"Kaminker J."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/author"Crawford Y."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/name"Cancer Cell"xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/pages"21-34"xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/title"PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment."xsd:string
http://purl.uniprot.org/citations/19111878http://purl.uniprot.org/core/volume"15"xsd:string
http://purl.uniprot.org/citations/19111878http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19111878
http://purl.uniprot.org/citations/19111878http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19111878
http://purl.uniprot.org/uniprot/#_B2R9K6-mappedCitation-19111878http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19111878
http://purl.uniprot.org/uniprot/#_B4E3A5-mappedCitation-19111878http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19111878
http://purl.uniprot.org/uniprot/#_Q8CI19-mappedCitation-19111878http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19111878
http://purl.uniprot.org/uniprot/#_Q9NRA1-mappedCitation-19111878http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19111878
http://purl.uniprot.org/uniprot/B4E3A5http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/19111878
http://purl.uniprot.org/uniprot/Q9NRA1http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/19111878
http://purl.uniprot.org/uniprot/B2R9K6http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/19111878